Recent Happenings
New Patents
U.S. Patent 7,547,519 was issued on June 16, 2009, for methods of diagnosing multidrug-resistant tuberculosis. Lead inventor: Clifton E. Barry III, Ph.D., Laboratory of Clinical Infectious Diseases
U.S. Patent 7,531,352 was issued on May 12, 2009, for an inducible plasmid vector encoding TGF-beta and its use. Lead inventor: Warren Strober, M.D., Laboratory of Host Defenses
U.S. Patent 7,528,274 was issued on May 5, 2009, for acylthiols and component thiol compositions as anti-HIV and antiretroviral agents. Lead inventor: John K. Inman, Ph.D., Laboratory of Immunology
Recent Collaboration Agreements
NIAID and Merial Limited signed a CRADA for Identification of immunogenic salivary antigens from the sand fly Phlebotomus perniciosus in dogs. NIAID principal investigator: Jesus G. Valenzuela, Ph.D., Laboratory of Malaria and Vector Research
NIAID and Transave Inc. signed a CRADA for Study of liposomal amikacin for inhalation (Arikace™) in patients with nontuberculous mycobacterial lung disease. NIAID principal investigator: Steve Holland, M.D., Laboratory of Clinical Infectious Diseases (LCID); NIAID clinical investigator: Ken Olivier, M.D., LCID